Big Pharma is far too cosy with medical schools, researchers, professors – Dr EV Rapiti

Loading player...
While Dr EV Rapiti is largely known as a family physician, over four decades of frontline healthcare experience and his insatiable drive to keep up to date with medical advancements have made him a uniquely qualified medical generalist. Over the last two-and-a-half years, Dr Rapiti personally treated approximately 3,000 Covid-19 patients with a significantly high success rate. He ate, slept and breathed Covid-19 while mainstream media engulfed the world with - in Rapiti’s view - incorrect information intended to scare. In an interview with BizNews, he said with conviction that “nobody should have died of Covid” as proper, early management of the virus could, and should, have been implemented to treat patients with Covid-19. He also takes an unsparing swipe at Professor Salim Karim and the official narrative which, on principle, Rapiti refused to follow, instead opting to do whatever was necessary to save his patients. Learn more about your ad choices. Visit megaphone.fm/adchoices
11 Jul 2022 8AM English South Africa Investing · Business News

Other recent episodes

BN Daybreak: Iran war oil surge; Apple sues OpenAI; Endres on SA's fixed investment woes

In today's BizNews Daybreak we cover the escalating US-Iran conflict and its impact on soaring crude oil prices. In South Africa, Dr. John Endres critiques low fixed investment rates, SARU faces backlash over overpriced Springbok tickets, and over 53,000 undocumented foreign nationals are successfully repatriated. Finally, Apple hits OpenAI with…
13 Jul 11PM 18 min

BizNews Edge: Why the IRR's John Endres is more bullish on SA than Britain

John Endres, CEO of the Institute for Race Relations, tells BizNews that the elite consensus defending BEE is cracking, even as its beneficiaries defend it loudest. He points to the Starlink saga - blocked partly over empowerment shareholding while a pricier, slower rival wins state favour - as proof the…
13 Jul 8AM 24 min

A world-first: the bond that pays out when nature wins

In this BizNews interview, Irakli Rekhviashvili sits down with the three people behind FirstRand's R2.5 billion Cape Water Performance-Based Bond, the first time a commercial bank anywhere in the world has tied a bond's payout to nature. The Nature Conservancy's Louise Stafford traces it to 2018, when Cape Town's dams…
12 Jul 8AM 15 min